1. Home
  2. CBAT vs OKUR Comparison

CBAT vs OKUR Comparison

Compare CBAT & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBAT
  • OKUR
  • Stock Information
  • Founded
  • CBAT 1999
  • OKUR 2011
  • Country
  • CBAT China
  • OKUR United States
  • Employees
  • CBAT N/A
  • OKUR N/A
  • Industry
  • CBAT Industrial Machinery/Components
  • OKUR
  • Sector
  • CBAT Miscellaneous
  • OKUR
  • Exchange
  • CBAT Nasdaq
  • OKUR NYSE
  • Market Cap
  • CBAT 71.6M
  • OKUR 76.6M
  • IPO Year
  • CBAT N/A
  • OKUR N/A
  • Fundamental
  • Price
  • CBAT $0.71
  • OKUR $2.60
  • Analyst Decision
  • CBAT
  • OKUR Strong Buy
  • Analyst Count
  • CBAT 0
  • OKUR 4
  • Target Price
  • CBAT N/A
  • OKUR $32.25
  • AVG Volume (30 Days)
  • CBAT 176.0K
  • OKUR 74.0K
  • Earning Date
  • CBAT 05-09-2025
  • OKUR 05-14-2025
  • Dividend Yield
  • CBAT N/A
  • OKUR N/A
  • EPS Growth
  • CBAT N/A
  • OKUR N/A
  • EPS
  • CBAT 0.13
  • OKUR N/A
  • Revenue
  • CBAT $176,614,609.00
  • OKUR N/A
  • Revenue This Year
  • CBAT $28.79
  • OKUR N/A
  • Revenue Next Year
  • CBAT $36.77
  • OKUR N/A
  • P/E Ratio
  • CBAT $5.54
  • OKUR N/A
  • Revenue Growth
  • CBAT N/A
  • OKUR N/A
  • 52 Week Low
  • CBAT $0.57
  • OKUR $2.50
  • 52 Week High
  • CBAT $2.08
  • OKUR $20.00
  • Technical
  • Relative Strength Index (RSI)
  • CBAT 44.55
  • OKUR N/A
  • Support Level
  • CBAT $0.63
  • OKUR N/A
  • Resistance Level
  • CBAT $0.74
  • OKUR N/A
  • Average True Range (ATR)
  • CBAT 0.06
  • OKUR 0.00
  • MACD
  • CBAT 0.01
  • OKUR 0.00
  • Stochastic Oscillator
  • CBAT 71.65
  • OKUR 0.00

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.

About OKUR ONKURE THERAPEUTICS INC

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Share on Social Networks: